Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief ...

A research team has discovered a mechanism in which blood stem cells respond to acute, severe anemia, through lipoprotein metabolism modification. It has been known how immediate erythroid precursors ...

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

An overabundance of cloned white blood cells hampers the immune system and increases the risk of melanoma, a new study finds.

At a median follow-up of 18 months, the OS rate was 95% and the DFS rate was 88%. 14 Long-term follow-up at a median of 53 ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...

The following is a summary of “A New Clinical Age of aging research,” published in the September 2024 issue of Endocrinology by Zhang et al. Aging is a significant risk factor for numerous diseases, ...

Danish patients who were diagnosed with certain lymphomas and other B-cell malignancies demonstrated increased antimicrobial ...